Growth inhibition and apoptosis induced by 2-phenoxymethyl-3H-quinazolin-4- one in HL-60 leukemia cells

Experimental Oncology

Volumn 29, Issue 1, 2007, Pages 13-17

  Cipak, L ^a   Repicky, A ^b   Jantova, S ^b  

^a CANCER RESEARCH INSTITUTE   (Slovakia)

^b SLOVAK UNIVERSITY OF TECHNOLOGY   (Slovakia)

Author keywords

Apoptosis; Cell cycle arrest; Leukemia; Quinazoline

Indexed keywords

2 PHENOXYMETHYL 3H QUINAZOLIN 4 ONE; ANTINEOPLASTIC AGENT; BUTHIONINE SULFOXIMINE; CASPASE 3; CASPASE 9; DNA FRAGMENT; GLUTATHIONE; REACTIVE OXYGEN METABOLITE; TRYPAN BLUE; UNCLASSIFIED DRUG;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CELL CYCLE; CELL CYCLE G1 PHASE; CELL CYCLE S PHASE; COLORIMETRY; CONTROLLED STUDY; CYTOTOXICITY; DRUG EFFECT; DRUG SYNTHESIS; ENZYME ACTIVATION; ENZYME ACTIVITY; FLOW CYTOMETRY; GLUTATHIONE METABOLISM; GROWTH INHIBITION; HUMAN; HUMAN CELL; LEUKEMIA CELL;

APOPTOSIS; CASPASE 3; CASPASE 9; CELL CYCLE; CELL PROLIFERATION; DOSE-RESPONSE RELATIONSHIP, DRUG; FLOW CYTOMETRY; GLUTATHIONE; HL-60 CELLS; HUMANS; MITOCHONDRIA; PROTO-ONCOGENE PROTEINS C-BCL-2; QUINAZOLINES; REACTIVE OXYGEN SPECIES;

EID: 34248157771     PISSN: 18129269     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. Cai SX, Drewe J, Kasibhatla S. A chemical genetics approach for the discovery of apoptosis inducers: from phenotypic cell based HTS assay and structure-activity relationship studies, to identification of potential anticancer agents and molecular targets. Curr Med Chem 2006; 13: 2627-44.
2. Bremer E, van Dam G, Kroesen BJ, de Leij L, Helfrich W. Targeted induction of apoptosis for cancer therapy: current progress and prospects. Trends Mol Med 2006; 12: 382-93.
3. Philchenkov A, Zavelevich M, Kroczak TJ, Los M. Caspases and cancer: mechanisms of inactivation and new treatment modalities. Exp Oncol 2004; 26: 82-97.
4. Jantova S, Theiszova M, Mikulasova M. Cytotoxic and genotoxic effects of some substituted tetrazolo[1,5-c]quinazolines. Neoplasma 2004; 51: 436-41.
5. Jantova S, Ovadekova R, Letasiova S, Spirkova K, Stankovsky S. Antimicrobial activity of some substituted triazoloquinazolines. Folia Microbiol 2005; 50: 90-4.
6. Alagarsamy V. Synthesis and pharmacological investigation of some novel 2-methyl-3-(substituted methylamino)-(3H)-quinazolin-4-ones as histamine H1-receptor blockers. Pharmazie 2004; 59: 753-5.
7. Maarouf AR, El-Bendary ER, Goda FE. Synthesis and evaluation of some novel quinazolinone derivatives as diuretic agents. Arch Pharm 2004; 337: 527-32.
8. Chan DC, Anderson AC. Towards species-specific antifolates. Curr Med Chem 2006; 13: 377-98.
9. Buter J, Giaccone G. EGFR inhibitors in lung cancer. Oncology 2005; 19: 1707-11.
10. Zhou Y, Hu YP, Wang J, Hauser J, Conway AN, Vinci MA, Humphrey L, Zborowska E, Willson JK, Brattain MG. Blockade of EGFR and ErbB2 by the novel dual EGFR and ErbB2 tyrosine kinase inhibitor GW572016 sensitized human colon carcinoma GEO cells to apoptosis. Cancer Res 2006; 66: 404-11.
11. Skibo EB, Huang X, Martinez R, Lemus RH, Craigo WA, Dorr RT. Pirimidoquinazoline-based antitumor agents. Design of topoisomerase II to DNA cross-linkers with activity against protein kinases. J Med Chem 2002; 45: 5543-55.
12. Cipak L, Letasiova S, Repicky A, Jantova S. New [1,2,4]triazolo[4,3-c]quinazoline enhances cisplatin- and temozolomide-induced growth inhibition and apoptosis in HL-60 cells. Neoplasma 2007; 54: 16-20.
13. Premkumar DR, Arnold B, Pollack IF. Cooperative inhibitory effect of ZD1839 (Iressa) in combination with 17-AAG on glioma cell growth. Mol Carcinog 2006; 45: 288-301.
14. Spirkova K, Stankovsky S, Mrvova A, Cipak L. Synthesis and biological activity of some 2-substituted quinazoline-4-ones. Chem Papers 1999; 53: 272-5.
15. Bathini Y, Singh I, Harvey PJ, Keller PR, Singh R, Micetich RG, Fry DW, Dobrusin EM, Toogood PL. 2-Aminoquinazoline inhibitors of cyclin-dependent kinases. Bioorg Med Chem Lett 2005; 15: 2881-5.
16. Chang GC, Hsu SL, Tsai JR, Liang FP, Lin SY, Sheu GT, Chen CY. Molecular mechanism of ZD1839-induced G1-cell cycle arrest and apoptosis in human lung adenocarcinoma A549 cells. Biochem Pharmacol 2004; 68: 1453-64.
17. Geller JI, Szekely-Szucs K, Petak I, Doyle B, Houghton JA. P21Cip1 is a critical mediator of the cytotoxic action of thymidilate synthase inhibitors in colorectal carcinoma cells. Cancer Res 2004; 64: 6296-303.
18. Shi MM, Kugelman A, Iwamoto T, Tian L, Forman HJ. Quinone-induced oxidative stress elevates glutathione and induces gamma-glutamylcysteine synthase activity in rat lung epithelial L2 cells. J Biol Chem 1994; 269: 26512-7.
19. Wang IK, Lin-Shiau SY, Lin JK. Induction of apoptosis by apigenin and related flavonoids through cytochrome c release and activation of caspase-9 and caspase-3 in leukemia HL-60 cells. Eur J Cancer 1999; 35: 1517-25.
20. Cipak L, Paulikova H, Novotny L, Jarosova M, Rauko P. Potentiation of doxorubicin-induced apoptosis and differentiation by indomethacin in K-562 cells. Neoplasma 2004; 51: 188-92.
21. Schnelldorfer T, Gansauge S, Gansauge F, Schlosser S, Beger HG, Nussler AK. Glutathione depletion causes cell growth inhibition and enhanced apoptosis in pancreatic cancer cells. Cancer 2000; 89: 1440-7.